Michigan state lawmakers and representatives for drugmakers, providers, and business groups debated a 340B contract pharmacy access bill during a [...] …
Category: Trade Association
A House oversight hearing this week added to the growing debate over the 340B program’s future as federal lawmakers continue [...] …
A key House subcommittee oversight hearing today on the 340B program will include a witness who previously said Congress should [...] …
A major national 340B provider advocacy group is condemning the newly introduced 340B ACCESS Act, arguing that the proposed overhaul [...] …
A federal appeals court’s decision this week to uphold two drugmakers’ 340B contract pharmacy restrictions left unanswered questions about the [...] …
Medicare Part D beneficiaries who received retail and specialty drugs from prescribers at 340B disproportionate share hospitals (DSH) were more [...] …
The 340B program continued to expand in 2023, exceeding $124 billion in wholesale acquisition cost (WAC) sales—up from $107 billion [...] …
Groups representing hospitals that rely on the 340B program recently urged congressional advisers against recommending reduced Medicare reimbursement to 340B [...] …
The 340B drug discount program—and congressional activity associated with it—remained a hot topic for lobbyists in the first three months [...] …
A drug industry vendor and a conservative non-profit each urged a full federal appeals court to rehear a case on [...] …